Open Label Drug Interaction Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) 100mg On The Pharmacokinetics Of Aripiprazole When Coadministered To Healthy Subjects

NCT01188668 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

38

Enrollment

INDUSTRY

Sponsor class

Conditions

Pharmacokinetics
Cytochrome P-450 CYP2D6
CYP3A4 Protein, Human

Interventions

DRUG: Aripiprazole
DRUG: Aripiprazole + desvenlafaxine succinate sustained release

Sponsor

Pfizer